Cochlear Limited
CHEOF · OTC
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 5.17 | 3.19 | 12.77 | -4.16 |
| FCF Yield | 0.73% | 1.40% | 1.80% | 2.32% |
| EV / EBITDA | 29.78 | 36.51 | 29.73 | 26.39 |
| Quality | ||||
| ROIC | 13.45% | 16.22% | 14.54% | 14.65% |
| Gross Margin | 73.74% | 74.86% | 74.79% | 75.07% |
| Cash Conversion Ratio | – | – | 1.21 | 1.30 |
| Growth | ||||
| Revenue 3-Year CAGR | 6.57% | 10.69% | 8.94% | 7.67% |
| Free Cash Flow Growth | -54.85% | 12.20% | -10.96% | 50.63% |
| Safety | ||||
| Net Debt / EBITDA | -0.06 | -0.47 | -0.73 | -0.79 |
| Interest Coverage | 36.92 | 51.63 | 41.44 | 46.79 |
| Efficiency | ||||
| Inventory Turnover | 1.23 | 1.44 | 1.57 | 1.52 |
| Cash Conversion Cycle | 210.52 | 137.52 | 103.96 | 101.86 |